Neufeld Leah R's Form 4 filing
Immuneering Corp (IMRX) · filed Mar 21, 2024
- Accession no.
- 0001790340-24-000036
- Filed
- Mar 21, 2024
- Trade date
- Mar 15-20, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $11.0K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Neufeld Leah RCIK 0001950673 | Officer (CHIEF PEOPLE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Class A Common Stock | AGrant or awardAcquired | +6,211 | $1.62F3 | +$10,061.82 | 6,211 | Direct | |
| Mar 20, 2024 | Class A Common Stock | PPurchaseAcquired | +3,818 | $2.88 | +$10,995.84 | 10,029 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Purchase Date of March 15, 2024.
Referenced by the price of 1 transaction in Table I.